Life Sciences 2017: Analysis
As ever, our legal analysis seeks to identify which law firms and which lawyers are the most highly regarded practitioners both by region and by type of life sciences law. We have split our research into four practice areas: transactional, patent litigation, product liability and regulatory. Europe and the United States once again emerge as the regions with the greatest concentration of top life sciences lawyers. However, while smaller in volume, Australia, China and Japan’s leading law firms also demonstrate their depth of expertise in the area, with numerous individuals recommended across all areas.
|1. Nicola Dagg||Allen & Overy, London|
|2. Miquel Montañá||Clifford Chance, Barcelona|
|3. Brian Cordery||Bristows, London|
|1. Ina Brock||Hogan Lovells, Munich|
|2. John Meltzer||Hogan Lovells, London|
|3. Isabel Foley||Arthur Cox, Dublin|
|1. Peter Bogaert||Covington & Burling, Brussels|
|2. Ian Dodds-Smith||Arnold & Porter Kaye Scholer, London|
|3. Maria Isabel Manley||Bristows, London|
|1. Malcolm Bates||Taylor Wessing, London|
|2. Patrick Duxbury||Gowling WLG, London|
|3. Tim Worden||Taylor Wessing, London|
HOGAN LOVELLS sees 21 practitioners listed in Europe, where some of its lawyers are the most highly regarded in our research.
In Düsseldorf, Andreas von Falck heads the international intellectual property, media and technology group and is regarded by his peers as “number one for IP litigation in life sciences in Germany”.
In Munich, “there is none better” than Ina Brock, according to sources. She is recommended in our research for her product liability expertise including litigation and crisis communication.
Stephen Bennett has acted for numerous innovator clients on high-end patent litigation cases and is highly recommended in the market.
In Amsterdam, Klaas Bisschop is “a great patent litigator” who has over two decades’ worth of experience in complex disputes and has handled cases before Dutch and international courts as well as ICC arbitral panels.
Co-head of the global life sciences litigation arbitration and employment team, Cécile Derycke has expertise in contentious product liability issues. Sources comment that she “has a very reputed practice” and is “a very skilled lawyer who is an expert in pharmaceuticals”.
John Meltzer in London is considered “the dean of UK products work”. He has experience in cross-border product liability claims and has acted in numerous high-profile group actions relating to vaccines, blood products and pharmaceutical technology.
Caroline Moore acts for manufacturers of pharmaceuticals and medical devices on product liability issues. She is noted as “very knowledgeable and very good on the law”.
In Paris, Thomas Rouhette specialises in product liability and toxic torts litigation and is “an established leader in Europe. He is a seasoned lawyer with a wide, diverse practice.”
The “fantastic” Sebastian Lach is an expert in complex product safety and liability cases and handles investigations, criminal cases and compliance matters.
Francesca Rolla in Milan has expertise a wide array of product liability cases including drug recalls and medical device side effects. He is regarded as “an excellent, go-to person for contentious product liability matters”.
Head of the firm’s Netherlands regulatory practice Hein van den Bos specialises in EU matters and has helped numerous pharmaceutical, biotech and medical devices companies on issues of development, approval and marketing.
Elisabethann Wright in Brussels is an expert in regulatory issues and advises clients on classification, authorisation and marketing of products in the EU. She is described by her peers as “a wonderful lawyer who is very visible in the market”.
Natalia Gulyaeva in Moscow is head of the life sciences practice for Russia and the CIS. She has vast experience working in the high-tech, pharmaceuticals and biotechnology fields on both transactional and regulatory issues. One client recommends her for “her ability to demonstrate a very client-centred approach, as well as her professionalism, creativity and an orientation towards business objectives”.
BIRD & BIRD achieves 20 listings across 11 countries in Europe, with a strong emphasis on pan-European patent litigation.
In London, Mark Hilton is described as a “definite inclusion” for patent litigation work. His “strong practice” includes notable experience in pan-European patent cases.
Neil Jenkins offers clients 30 years of experience in cross-border patent litigation. He is “reliable, effective and highly knowledgeable”.
The “very experienced” Morag Macdonald is recognised by peers as a leader in IP litigation and is highly regarded for her patent disputes expertise.
Jennifer Jones focuses on pan-European patent litigation and disputes. One client says of her: “Jenny is very calm under pressure and can provide excellent, up-to-date strategic insight. She is superb in very complex multiparty action cases”.
In The Hague, Marc van Wijngaarden is head of the firm’s life sciences group for the Netherlands and specialises in patent matters. He is regarded as “legally astute and a great patent litigator”.
The highly experienced Wouter Pors heads the Netherlands intellectual property department and is regarded as a leader in patent disputes.
In Madrid, Manuel Lobato is regarded as an expert patent litigator who also handles transactions in the life sciences space, including joint ventures and due diligence matters. In Düsseldorf, Christian Harmsen specialises in international patent litigation of technical areas and has led proceedings for some of the world’s largest pharmaceutical companies. He is noted for his “impressive expertise” and described as “someone who has his finger on the pulse”.
Michael Alt is well regarded for his patents expertise. An experienced litigator, he is highlighted as one of the leading life sciences practitioners in Germany.
Oliver Jan Jüngst continues to be regarded as one of the leading litigators in the life sciences field with notable expertise in German and European patent matters.
The “superb” Yves Bizollon in Paris deals with significant cross-border patent litigation across Europe. He has over 25 years of experience in the area. In Milan, Giovanni Galimberti is an IP and patent litigation expert who has “an academic level of knowledge about this area of law”.
Massimiliano Mostardini advises a multitude of clients in the public and private sector on pan-European patent litigation and is regarded by peers as a “very good practitioner and a formidable opponent”.
Ella Mikkola acts extensively in patent, trademark and design litigation. One peer remarks: "She really knows her stuff when it comes to IP and patent litigation."
The highly recommended Sally Shorthose focuses on commercial and licensing matters in the life sciences sector, including due diligence and R&D work.
Marc Martens in Brussels is head of the firm’s regulatory, public and administrative law group. He is considered “a top gun” in regulatory matters by impressed sources.
Mauro Turrini has a strong background in pharmaceuticals and is particularly recommended for his “ability to deal with complex regulatory matters”.
“Excellent commercial lawyer” Stefan Münch is a transactional specialist who acts on behalf of clients in both national and international mergers and acquisitions.
Specialised IP boutique HOYNG ROKH MONEGIER demonstrates its strong European market share with 15 listings, six of whom are in the Netherlands.
Managing partner Willem Hoyng is “a dean of the profession” and a seasoned patent litigator who has appeared before all national courts as well as the CJEU and the EPO.
In Brussels, Liesbeth Weynants is “a go-to person for patent litigation and regulatory issues in life sciences”. Her clients include pharmaceutical, medical devices and medical products companies.
In Paris, Benoît Strowel is listed in our patent litigation chapter for his expertise and experience working with some of the world’s most prominent pharmaceutical companies.
In Düsseldorf, Tobias Hahn specialises in patent litigation and subsequent damages proceedings for national and international life sciences clients.
In Amsterdam, Carla Schoonderbeek is widely recognised as being “top of the market in regulatory matters” by peers. for her expertise in European regulatory law pertaining to pharmaceuticals, biologicals and medicinal products.
Founding partner Simon Dack is listed in our patent litigation chapter and uses his background as both a barrister and a chemist to strong effect in patent cases.
The “always reliable” Bart Jong specialises in regulatory matters involving pharmaceuticals and biologicals in both the Dutch and the wider European markets.
The UK’s BRISTOWS, known for working with innovative clients and technologies, sees 10 practitioners listed.
Maria Isabel Manley is head of the firm’s regulatory department and is regarded as one of our thought leaders in the regulatory space. She specialises in IP matters and regulatory issues in the UK and Europe relating to bio-pharmaceutical and chemical products and medical devices and is recognised as “superb, a top regulatory lawyer and one of the best in the EU”.
Joint patent litigation head Brian Cordery has over two decades of experience in pharmaceutical patent litigation. He is recommended as “one of the best” by both peers and clients who comment that he is “a great patent and IP lawyer who “does a huge amount of work in the sphere”.
Laura Reynolds handles contentious IP matters and is an experienced patent litigator. She is also listed in our regulatory chapter. Sources comment that “she has really deep experience on multi-jurisdictional litigation”.
Sally Field is a very highly regarded patent litigator with exceptional experience and expertise in the area. She frequently assists clients with matters in the UK, Europe and the US.
Liz Cohen has represented clients in patent litigation cases in all courts including the Supreme Court and has also coordinated cross-border litigation. She is “very calm under pressure, extremely good with clients, and gives good strategic advice – the all-round package”.
The “very responsive” Robert Burrows is a seasoned patent litigator who has considerable knowledge of cross-jurisdictional European litigation.
ALLEN & OVERY sees nine lawyers recommended from across their European offices in Belgium, France, England, Germany, the Netherlands and Poland.
In London, solicitor-advocate Nicola Dagg is head of the IP litigation practice and is recommended as a thought leader in our research for patent litigation, She is “very well organised, always available, business-oriented and a team leader”, say interviewees.
Marjan Noor is recognised for her patent litigation practice and has “an excellent knowledge of SPC law”. She frequently acts for clients in English courts and before the CJEU.
Marc Döring is a member of the firm’s IP group and focuses on patent litigation in life sciences industries. He is highly recommended for his depth of knowledge and longstanding expertise in the area.
Jim Ford specialises in commercial and transactional work, with extensive knowledge in the pharmaceuticals and biotechnology industries.
In Paris, Laëtitia Bénard specialises in both contentious and non-contentious life sciences work and is “very good at what she does, a superb patents lawyer”.
In Munich, Joachim Feldges is highly respected by his peers for his complex patent litigation expertise, a field in which he has been practising for almost 30 years.
At COVINGTON & BURLING nine European lawyers are recognised. Seven of these are in the London office, which includes a strong transactional contingent.
In Brussels, Peter Bogaert has regulatory expertise under EC and national laws and has represented life sciences companies in litigation issues in court. He is regarded as “the grandfather of life sciences regulatory practice, with a very good reputation and a great practice”.
Adem Koyuncu advises on German and European regulatory and compliance issues regarding pharmaceuticals, medical devices and medical products.
In London, Grant Castle has expertise in pharmaceutical and medical device regulation and advises numerous multinational life sciences corporations. Peers “rank him very highly”, describing him as “a great regulatory lawyer”.
Daniel Pavin is a transactional expert with a particular focus on the IP aspects of M&A and strategic investments in the life sciences sector.
James Halstead advises on mergers and acquisitions, IPOs and commercial transactions including technology transfers, IP pipeline arrangements and joint ventures.
TAYLOR WESSING achieves nine recommendations in their offices throughout Europe, with five of those lawyers based in London.
Tim Worden is recognised as one of the leading regulatory lawyers in the life sciences space. He advises on partnering and licensing deals, R&D and a range of clinical trials regulation. He “always covers the ground and his in-house experience makes him very practical”, say sources who also praise him as “a very prestigious practitioner in the field”.
Simon Cohen specialises in patent litigation and is often involved in cross-border and parallel litigation in Europe and the US. He “has enjoyed numerous successes in cases in pan-European proceedings”.
The “excellent” Nigel Stoate specialises in patent litigation for pharmaceuticals companies and has acted in a number of high-profile patent cases in the High Court and Court of Appeal.
Malcolm Bates receives a very high number of nominations in our research and is recommended for his “deep market knowledge and transactional expertise”. He advises on major deals in the life sciences sector, including licensing and collaborations matters.
Specialist IP set 8 NEW SQUARE sees nine barristers recommended for their life sciences expertise.
Charlotte May QC has vast experience in patent litigation in the life sciences industry and is regarded as “one of the best QCs in this area”.
Andrew Lykiardopoulos QC has a broad experience in patent litigation in the life sciences sector and frequently appears before the European Patent Office. He is thought of very highly by his peers for his “expert knowledge and effective execution”.
The “excellent” and “exceptional” Richard Meade QC specialises in technically complex patent disputes often covering multiple jurisdictions.
Daniel Alexander QC has over two decades’ experience of patent litigation and is “very highly thought of” for his work on EU and international cases involving biotechnology and pharmaceuticals patents.
ARNOLD & PORTER KAYE SCHOLER sees eight European lawyers listed, with all but one of them part of the firm’s standout London office.
Ian Dodds-Smith is one of the most nominated lawyers in our research. He is highly regarded for his knowledge of the European regulatory framework and advises life sciences companies and trade associations. He is considered “top of the list in terms of excellence; the guru of pharmaceuticals legislation in Europe”.
Lincoln Tsang is noted as “the best guy in Europe for regulatory matters” by one source. He has a background as a senior regulator and advises on regulatory, compliance and enforcement issues.
Adela Williams advises on regulatory matters pertaining to medicinal products and medical devices in both the UK and the EU. She also has expertise in pricing and reimbursement issues.
Leading UK-based life sciences boutique POWELL GILBERT sees seven lawyers listed this year.
The widely renowned Penny Gilbert tops the list. Her expertise is in patent litigation, where she represents clients in all levels of English court as well as before the CJEU and the EFTA court. She is “very well regarded, and rightly so”.
Solicitor-advocate Tim Powell specialises in multi-jurisdictional patent litigation. He is regarded as “technically excellent and capable of representing people at the highest levels”.
Tim Whitfield has strong experience in contentious IP matters, particularly patent litigation, where he is praised as “indispensable; one of the best in the market”.
Zoë Butler has been involved in numerous multi-jurisdictional patent disputes and has strong knowledge of the EU patents court. She “gives a depth of knowledge and the client can rest assured that she knows her stuff”.
Bethan Hopewell focuses on patent litigation in high-tech industries, including pharmaceuticals and biotechnology, where she is “very strong on the technical stuff; a great disputes lawyer”.
Alex Wilson specialises in IP and contract disputes generally and is listed for his patent litigation expertise. He is noted as “an all-round excellent legal mind”.
David Lancaster has strong experience in the life sciences sector and has built a respected practice as a patent litigator.
GOWLING WLG’s London office achieves three listings.
Head of life sciences Patrick Duxbury is recommended in our research as a thought leader. He has strong expertise in structuring and executing transactions for clients in the life sciences sector and is also noted as “a fantastic source of knowledge on IP licensing”.
Paul Inman stands out for his deep expertise in patent litigation and IP disputes involving the life sciences sector. He is regarded as “practical and effective; a problem-solver”.
Gordon Harris is noted for his intellectual property expertise, with sources particularly highlighting him as “highly knowledgeable on enforcement, protection and across the patents field”.
Three lawyers from patents boutique MARKS & CLERK SOLICITORS are recommended.
Will James advises on patents issues relating to pharmaceuticals, medical devices and biotechnology. One peer says, “I would certainly consider Will to be one of the best in the industry. He genuinely cares about his clients and his advice is always commercial and highly relevant.”
Mike Gilbert is identified as one of the leading patent litigators in England in this year’s research. He is highly recommended for expertise in pharmaceuticals and biotechnology.
Graham Burnett-Hall specialises in patent litigation relating to medical devices where “he can really get to grips with complex or specialised cases”.
SIDLEY AUSTIN’s European contingent numbers two lawyers.
Maarten Meulenbelt in the Brussels office is highly regarded for his regulatory expertise. Clients recommend him as a “highly specialised expert” who has “in-depth knowledge of the industry in the Netherlands and the EU”.
Maurits Lugard is leader of the EU life sciences regulatory and compliance team. He is regarded as “highly experienced; one of the foremost experts in life sciences regulatory issues”.
Belgium’s VAN BAEL & BELLIS achieves two recommendations in the regulatory field.
Peter L'Ecluse specialises in competition and IP rights including pricing and reimbursement matters. One peer says, “He is a definite inclusion, very accomplished."
Catherine Longeval is “outstanding” and is noted for her knowledge of the laws governing pharmaceuticals, biotechnology and medical devices.
At CMS ADONNINO ASCOLI & CAVASOLA SCAMONI in Rome, Paola Ghezzi is listed for her experience in product liability disputes, including litigation and arbitration. One respondent says, “She provides superb technical preparation, reliability, professionalism and commitment to the client and objective.”
Paola Sangiovanni of GITTI AND PARTNERS comes highly recommended in our transactional, regulatory and product liability chapters as “a rising star” who is “highly competent, gives timely feedback and has great experience in biomedical and life sciences”.
Christian Bouckaert of BOUCKAERT ORMEN PASSEMARD has considerable expertise in product liability matters in the pharmaceuticals sector. One respondent says: “He is without a doubt one of the most distinguished and preeminent lawyers operating in France today.”
Mikkel Vittrup at PLESNER LAW FIRM in Copenhagen advises on a number of regulatory issues including pharmaceuticals, medical devices and IP issues. One client says of him: “He is a careful listener who gives high-quality advice and is commercially minded.”
ARTHUR COX’s Isabel Foley is highly regarded in our research for her product liability expertise and has advising government bodies, companies and financial institutions in commercial disputes. She is “highly recommended – the go-to lawyer in Ireland”.
At CLIFFORD CHANCE in Barcelona, Miquel Montañá specialises in patent disputes relating to life sciences. He represents multinational pharmaceutical companies and is praised for his “deep knowledge and experience of the field”.
Charles Waddell at PINSENT MASONS is recognised as one of our thought leaders in the transactional space, where he has expertise in M&A, IPOs and joint ventures. He is recognised for his “strong transactional background and understanding of how to makes deals happen”.
Patricia Barclay of BONACCORD ECOSSE is recognised as a dynamic and business-oriented lawyer in the pharmaceuticals industry, where she has been a key figure for almost two decades.
|1. William Gaede||McDermott Will & Emery, Silicon Valley|
|2. Nicholas Groombridge||Paul Weiss Rifkind Wharton & Garrison, New York, NY|
|3. Morgan Chu||Irell & Manella, Los Angeles|
|1. Christy D Jones||Butler Snow, Jackson, MS|
|2. Tripp Haston||Bradley Arant Boult Cummings, Birmingham|
|3. Gordon McKee||Blake Cassels & Graydon, Toronto|
|1. Daniel A Kracov||Arnold & Porter Kaye Scholer, Washington, DC|
|2. Peter O Safir||Covington & Burling, Washington, DC|
|3. Jeffrey Shapiro||Hyman Phelps & McNamara, Washington, DC|
|1. Barbara Kosacz||Cooley, Palo Alto|
|2. Fred Muto||Cooley, San Diego|
|3. Marc Rubenstein||Ropes & Gray, Boston|
SIDLEY AUSTIN achieves an impressive 32 listings in the USA, 11 of which are in Illinois; 11 are in Washington, DC; six are in California; and four are in New York.
Maja Eaton is global leader of the products liability and mass torts practice and has vast experience in product liability litigation including toxic torts. She is “a real expert who is very visible in the market”.
In Chicago, Sara Gourley is highly regarded for her product liability litigation capabilities in pharmaceutical, medical devices and blood products. She is “amazing and highly sought after by companies”.
Eugene Schoon is a prominent practitioner in Illinois who focuses on pharmaceutical and medical devices product liability litigation.
Kara McCall specialises in defence of companies against class action litigation, product liability and mass torts. She is regarded as “a formidable lawyer who can get results for her clients”.
The “very good and highly responsive” Heidi Levine specialises in product liability and mass torts with a focus on pharmaceutical and medical devices litigation.
Debra Pole in Los Angeles focuses on product liability litigation and is an expert in multi-district litigation. She is known as “an excellent trial lawyer”.
The “highly specialised and pragmatic” Elizabeth Curtin has over a decade of experience in advising and defending complex litigation matters.
Jeffrey Kushan focuses on patent litigation, appeals and proceedings and is “very talented, the go-to guy in patent litigation”, according to one interviewee.
In the New York office, Scott Bass heads the firm’s global life sciences team and specialises in FDA- related regulatory issues. He is recommended by peers as “a senior lawyer with an outstanding and recognised reputation”.
In Washington, DC, Coleen Klasmeier heads the firm’s food, drug and medical device regulatory practice. One leading international lawyer calls Klasmeier “the best pharmaceutical regulatory lawyer in the US”.
William Sarraille specialises in healthcare regulation including pricing and reimbursement, coding and coverage and market issues. He is “an excellent lawyer and highly regarded in the healthcare sector”.
Paul Kalb is a regulatory healthcare specialist and represents some of the largest drug, biotechnology and devices manufacturers in the country.
William McConagha specialises in enforcement, regulatory and legislative matters and is a “very high-quality practitioner” according to peers.
Sharon Flanagan in San Francisco has represented pharmaceuticals and biotech companies in transactional matters for over 20 years. She is “a great M&A attorney with a high profile.”
COVINGTON & BURLING achieves 14 listings across three US states, with the vast majority located in the Washington, DC office.
Peter Safir is one of our thought leaders in the regulatory space and has advised clients on regulatory matters in the food and drug industry for over 25 years. One peer comments that Safir is “the one who I would call for regulatory issues if I were a client”.
Richard Kingham has acted for numerous pharmaceutical and biotech companies on regulatory and compliance issues, where he is considered to be one of the leaders in the field.
Ellen Flannery is “one of the best” when it comes to regulatory strategies and compliance for pharmaceutical products and medical devices.
Scott Cunningham has expertise in regulatory issues represents life sciences companies and trade associations before the FDA. He is recommended as “absolutely terrific with great client skills”.
Michael Labson is recognised for the quality of her strategic advice provided to pharmaceutical and biotechnology companies in relation to FDA regulations.
Head of the firm’s technology transactions group John Hurvitz advises both established and emerging life sciences companies on transactional matters and strategy. He is recognised as “really terrific and highly recommended – clients love him”.
“Go-to guy” Peter Barton Hutt is regarded for his transactional and regulatory expertise. He represents a wide array of companies and trade associations and is noted as “the best guy in the business”.
COOLEY LLP sees 13 of its lawyers listed across Washington, DC; Virginia, Massachusetts; and its home state of California.
Barbara Kosacz in Palo Alto is the top US lawyer in our transactional chapter this year, recognised for her work with start-ups, large companies and venture funds. She is regarded variously as an “excellent lawyer” and “a standout performer” by commentators.
Fred Muto in San Diego is also recognised as one of our thought leaders. He is a transactions specialist who focuses particularly on emerging technologies and growth companies. Sources describe him as being “at the top of his game”.
Jane Adams is recommended for her experience advising public and private life sciences companies on transactional issues including strategic alliances and research and development collaborations.
Bob Jones is listed in our transactional chapter and has decades of experience, primarily representing technology companies in the life sciences sector.
Kay Chandler represents public and private life sciences companies in transactional and commercial issues. She is widely regarded for her expertise broad client base.
In Washington, DC, Natasha Leskovsek advises pharmaceutical, biotechnology and medical device clients on regulatory and clinical development matters. She has significant FDA experience and peers highlight her as “a go-to lawyer if I had a conflict”.
HOGAN LOVELLS sees 12 lawyers listed in the USA for their expertise in life sciences, particularly in the regulatory space.
Philip Katz is highly regarded for his regulatory expertise, advising life sciences companies on FDA and compliance matters. He is recognised as “a leading figure in the market and a very skilled lawyer”.
Jonathan Kahan is an expert in regulatory issues in the life sciences market with a particular knowledge in obtaining FDA market clearance of medical devices.
Meredith Manning is an expert on existing and emerging regulatory issues relating to pharmaceuticals. She has considerable FDA and DOJ experience and is noted for her longstanding reputation and depth of knowledge in the area.
Helen Trilling has experience of government enforcement interests which she uses to advise healthcare companies in regulatory matters.
John Smith is “a medical devices expert” with a strong regulatory background. He is recommended for his ability to understand and help clients through FDA compliance issues including submission and administrative appeals.
Janice Hogan in Philadelphia is “incredibly experienced” and has vast experience of representing medical device companies before the FDA on issues of technology, healthcare and regulation.
GOWLING WLG achieves five listings across its Ontario and Alberta offices.
In Ottawa, Anthony Creber is praised for his “very strong practice”. He specialises in IP litigation and strategy and is head of the firm’s practice group in the area.
Christopher Van Barr is recommended for his patent litigation expertise, which includes extensive first-chair experience. He is described by commentators as “a real strategist with serious experience in the field”.
In Calgary, Patrick Stewart Smith is noted for his skill as a patent litigator in a wide range of life sciences disputes. One client says: “He has an excellent command of the subject matter as well as strong courtroom skills”.
In Toronto, Mary Thomson is recognised in our regulatory and product liability chapters and is regarded as one of the foremost practitioners in Canada. Peers praise her “very strong regulatory practice” and highlight her deep expertise in pharmaceutical and medical device matters.
Alan West is a specialist in pharmaceuticals and healthcare regulation, including pricing issues. Sources say, "He has a very strong regulatory practice."
At PAUL WEISS RIFKIND WHARTON & GARRISON in New York, patent litigator Nicholas Groombridge is “one of the top lawyers in the field”. He offers more than 25 years of experience in patent infringement cases.
Jennifer Gordon is noted for her expertise in complex patent litigation involving pharmaceuticals and biotechnology clients.
At Atlanta-born law firm ARNALL GOLDEN GREGORY, Alan Minsk is listed for his regulatory expertise in the pharmaceutical, biological and medical devices sectors. Peers say: “Alan’s breadth of knowledge and responsiveness is outstanding. I know he will always balance risk with practical reality”.
The “fantastic” Jennifer Downs Burgar focuses on regulatory and compliance issues in the healthcare sector on both federal and state levels.
Trevor Cook of WILMER CUTLER PICKERING HALE AND DORR specialises in IP matters relating to global patent litigation in life sciences. He is identified by our research this year as one of the top patent litigators in the USA.
William Lee is “a seasoned patent litigator” who has vast expertise in intellectual property law.
At BUTLER SNOW in Jackson, Mississippi, Christy Jones is a “leader in the field” who specialises in product liability cases. Interviewees note her as “an excellent trial lawyer who is out there trying a lot of cases”.
The “outstanding” Helen Kathryn Downs is a product liability litigation expert and is recognised as one of the best life sciences litigators in Alabama.
Orlando Richmond Sr is listed for his superb handling of mass tort litigations relating to pharmaceutical products.
James Barton Jr is highly regarded for his expertise in defending manufacturers and distributers in product liability issues including litigation.
At ARNOLD & PORTER KAYE SCHOLER’s Washington, DC office co-chair of the life sciences and healthcare regulation practice Daniel Kracov is listed as one of our thought leaders for his expertise in critical regulatory matters. He “has a great background and definitely belongs on the list”.
At CAMPBELL CAMPBELL EDWARDS & CONROY, firm president James Campbell is listed for his product liability expertise as well as for his reputation as a leading trial lawyer who can handle high-stakes cases. One respondent says: “He is a standout in the market who has been there a long time and knows how to get things done.”
John Lay Jr of GALLIVAN WHITE & BOYD is a "formidable lawyer", recommended for his high-stakes product liability litigation experience.
Lori Cohen of GREENBERG TRAURIG specialises in medical device and pharmaceutical litigation. She has vast experience in jury trials and is regarded by peers as “an excellent lawyer”.
Madeleine McDonough at SHOOK HARDY & BACON is a “superb” product liability litigator who advises and represents clients on a range of complex matters. She also handles preventive litigation and resolution strategies for clients in the pharmaceuticals and medical devices fields.
Michael Crim at MCNEER HIGHLAND MCMUNN & VARNER is rated as a top trial lawyer in the product liability space. One peer remarks, “He is skilled in numerous areas and I readily refer clients to him.”
Cathy Burgess at ALSTON & BIRD is a regulatory expert and product liability expert whose practice covers the pharmaceutical sector. One respondent says, “She’s really been there in terms of the life sciences market; she has an excellent grasp of how to get things done.”
Gordon McKee at BLAKE CASSELS & GRAYDON is praised for his expertise in defending class action lawsuits and serious liability claims. Colleagues say: “He is well regarded as a leading practitioner and a pleasure to deal with.”
Tripp Haston at BRADLEY ARANT BOULT CUMMINGS represents life sciences clients, including prominent global pharmaceutical companies, in product liability litigation. He is “top notch and internationally one of the best”, say sources.
Bruce Jenett in DLA PIPER’s Silicon Valley office specialises in life sciences transactional matters. Commentators highlight his “extensive experience, deep legal knowledge and good judgement. He has aa proactive, responsive approach and always has the customer in mind”.
The “truly excellent” William Gaede at MCDERMOTT WILL & EMERY focuses on patent litigation in the life sciences arena, acting for a number of prominent industry players.
Middle East and Asia-Pacific
|1. Tal Band||S Horowitz & Co, Tel Aviv|
|2. Odette Gourley||Corrs Chambers Westgarth, Sydney|
|3. Wayne McMaster||MinterEllison, Melbourne|
|1. Colin Loveday||Clayton Utz, Sydney|
|2. Andrew Morrison||Clayton Utz, Melbourne|
|3. Greg Williams||Clayton Utz, Sydney|
|Selma Toplu Ünlü||NSN Law Firm, Istanbul|
|Odette Gourley||Corrs Chambers Westgarth, Sydney|
CLAYTON UTZ demonstrates its pre-eminence in the Asia-Pacific life sciences market with seven lawyers listed in Australia.
Colin Loveday in Sydney is recognised as one of the world’s foremost product liability litigators. He is “preeminent, with great legal skills and experience. He is excellent on complex product matters”, say our interviewees.
Andrew Morrison in Melbourne is “a leading products partner” who defends high-profile class action claims in the pharmaceuticals industry. According to sources, Morrison is “attentive and highly knowledgeable”.
Greg Williams in Sydney is recognised in both our product liability and regulatory chapters for his diverse expertise handling litigation, including class-action claims. Peers regard him as “a seasoned partner who is really making his mark”.
Ross McInnes is listed in our product liability chapter and specialises in mass consumer disputes and risk management for clients. He is considered “a rising star” in the field.
John Collins in Sydney is “a leader” in patent litigator and head of the firm’s national IP and technology practice. According to peers, he has a “very good litigation ‘feel’ and clients love him”.
ALLENS sees four lawyers listed across Australia.
Sarah Matheson specialises in infringement and validity litigation and is regarded one of the foremost practitioners in the country in the area.
The “excellent” Peter O'Donahoo is highlighted for his expertise in product liability disputes involving the life sciences sector.
In Melbourne, Richard Hamer is a “standout practitioner” who handles a range of work in life sciences, including patent litigation and corporate transactions.
In Sydney, “leader in the field” Philip Kerr acts in complex, highly technical patent litigation, where he has an “excellent reputation” according to peers.
SIDLEY AUSTIN sees a strong regulatory contingent in its offices across the Asia-Pacific region.
China life sciences practice head Chen Yang in Sydney is listed for her expertise in regulatory and market entry issues for multinational life sciences companies. She is “one of the best in the region”.
In Hong Kong, the well-regarded Yuet Ming Tham advises pharmaceutical and medical device companies and local and regional regulatory issues.
Lei Li in Beijing specialises in regulatory matters in the pharmaceutical and medical device industry.
BIRD & BIRD’s Hong Kong office sees three practitioners listed for their leading patent litigation practices.
Alison Wong focuses on multi-jurisdictional patent litigation and advises more broadly on issues in the life sciences space. She is regarded as one of the top experts in the region.
Matthew Laight represents life sciences companies across Hong Kong and China on major IP litigation is well regarded for his strong all-round expertise in the field.
In Singapore, the highly experienced Alban Kang represents an array of well-known pharmaceutical companies in complex patent litigation.
DREW & NAPIER in Singapore has two listings, both of whom are specialists in regulatory issues in the life sciences market.
Benjamin Gaw is one of the region’s foremost lawyers in pharmaceutical and healthcare regulatory matters, as identified by our research.
Tony Yeo is recommended across our life sciences chapters for his wide-ranging expertise in the area.
At ABE IKUBO & KATAYAMA in Japan, Mami Hino has strong experience in the life sciences industry and is a highly regarded patent litigator. She “does a great job and gives good advice”.
Eiji Katayama is highly recommended for his skills as a patent litigator in cases involving life science elements.
NAGASHIMA OHNO & TSUNEMATSU in Tokyo has recommended lawyers in both the transactional and regulatory spaces.
Kensuke Suzuki focuses on cross-border transactions in the pharmaceuticals, medical and healthcare sectors. Peers say of him: “He is highly capable of handling cross-border matters, with in-depth knowledge and experience of dealing with the Japanese regulatory authority."
Kenji Utsumi is listed in our regulatory chapter for his expertise in regulatory and compliance issues relating to M&A and corporate finance transactions.
TILLEKE & GIBBINS in Thailand sees two practitioners recognised for their regulatory expertise.
Alan Adcock is recommended for his regulatory and intellectual property practice and is known as one of the best in the region. Peers say: “When I need expertise in Thailand, I send work his way.”
Siraprapha Rungpry focuses on regulatory issues in the life sciences space and advises a range of pharmaceutical clients.
At RAJAH & TANN in Singapore, Wee Hann Lim heads the M&A group and is highly regarded for his transactional and regulatory expertise in the life sciences field.
At J SAGAR ASSOCIATES in Bangalore, Sajai Singh is recommended for his transactional and regulatory expertise. He represents companies in the life sciences sector on mergers and acquisitions, joint ventures and strategic alliances.
In Istanbul, GÜN + PARTNERS’ Özge Atilgan Karakulak is listed for her expertise in the life sciences arena relating to IP and regulatory matters. She is regarded as “a highly specialised and reliable regulatory specialist who displays comprehensive knowledge and experience as well as superior professionalism”. Impressed interviewees describe her as “the first choice for patent litigation in Turkey”.
Selma Toplu Ünlü at NSN LAW FIRM focuses on regulatory, anti-corruption and compliance issues in pharmaceuticals and life sciences law. Peers say of her: “She is extremely good and really stands out".
CORRS CHAMBERS WESTGARTH’s Odette Gourley in Sydney is a regulatory specialist and leading patent litigator in the life sciences field. According to interviewees, Gourley is “a great strategist, has a good knowledge of the field and is extremely service-oriented and client-oriented”.
At NORTON ROSE FULBRIGHT, Bernard O’Shea in Melbourne is listed in our regulatory chapter for his expertise in the pharmaceutical and biotechnology industry. He is noted as “knowledgeable and responsive”.